Our Advisory Team

MARTIN F. BEXON MD

CLINICAL ADVISOR

  • Martin, a UK- and NZ-trained MD, has worked in pharma for 17 years and held positions in the UK, Switzerland and the US leading clinical development programs in oncology, immunology and internal medicine.

ROLAND TURCK MD

COMMERCIAL ADVISOR

  • Managing Partner of TurckBio, an international consulting firm focused on corporate strategy as well as on clinical and commercial strategies in oncology and other specialty medicine areas.

JOHN H. SAMPSON MD

CLINICAL ADVISOR

  • The Robert H. and Gloria Wilkins Distinguished Professor, inaugural chair of the Department of Neurosurgery at Duke University, and the most highly funded PI in neurosurgery by the NIH.

HOWARD TAG

Market Access Advisor

  • Howard Tag, founder of Tag & Associates, provides pricing, reimbursement and market access advice to medical technology developers and to investment, law and communication firms that serve health care manufacturers.

DR ROD BAKER

CMC Advisor

  • Rod is a Drug Development Advisor with over forty years industrial experience in biotech, pharmaceutical, agrochemical and animal health companies.

DR MARK POWELL

CMC Advisor

  • Founder of Mark Powell Scientific Limited to provide technical support for pre-clinical drug development with over 20 years of industry experience.